Undoubtedly, the role of FABP4, sCD36, and RBP4 as the potential biomarkers of obesity, metabolic syndrome, and cardiovascular diseases was also confirmed in our studies. Here, FABP4 is linked to obesity due to melanocortin 4 receptor deficiency.